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Introduction
Anti-Microbial Resistance (AMR) is both a clinical chal-
lenge and a public health threat as AMR infection worsens
patient clinical outcome and burden of health systems.
Cost of treatment, lengths of hospital stays, and morbidity
and mortality increased. Few studies have described the
prevalence of antimicrobial resistance in Oman, but those
studies are limited to either one hospital or one organism.
Objectives
This study aims to assess the prevalence of antimicrobial
resistance among the tertiary and secondary care govern-
mental hospitals in Oman.
Methods
This is a point-prevalence survey using the World Health
Organization (WHO) tool [1] conducted 16-22 March
2014. 11/15 (73.3%) of the referral and regional hospitals
of the country participated. Microsoft Excel used to collect
data on five AMR organisms; Methicillin-Resistant
Staphylococcus aureus (MRSA), Vancomycin-Resistant
Enterococci (VRE), Extended-spectrum b-lactamase (ESBL)
producing Enterobacteriaceae, Carbapenem-Resistant
Enterobacteriaceae (CRE), and Multi-Resistant Acineto-
bacter spp (MRAB). SSPS software used to describe the
overall results.
Results
254 bacterial isolates have been identified. 90 (35.4%) are
Gram positive {Staphylococcus aureus (13 isolates, 14.4%),
Enterococci spp (11, 12.2%) and others (66, 73.3%)}, while
164 (64.6%) are Gram negative {Enterobacteriaceaespp.
(120 isolates, 73.2%), Acinetobacter spp. (10, 6.1%), and
others (34, 20.7%)}. 47/254 (18.5%) isolates have AMR fea-
ture (either MRSA, VRE, ESBL, CRE or MRAB). 6 (60%)
are MRAB out of the 10 total Acinetobacter isolates.
Among the 73 isolates of E. coli, 24 (32.9%) isolates are
ESBL while no CRE identified. 10 (27%) ESBL isolates
recognized among the 37 Klebsiella pneumoniae and
2 (5.4%) are CRE. 4 MRSA isolates (30.8%) identified
among the Staphylococcus aureus. One sample (9%) is
VRE among the Enterococci spp.
Conclusion
The prevalence of resistance is higher in Acinetobacter, E.
coli, MRSA, Klebsiella, and Enterococci respectively. This
study is the first prevalence survey that covers multiple
organisms and many hospitals in Oman and provides
important baseline. Capacities are available in the partici-
pating hospitals to identify AMR organisms. Continual
and national surveillance is the optimal goal for the accu-
rate and generalized data on AMR.
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